IL110933A - Tripeptide antithrombotic ingredients, pharmaceutical preparations containing them and their uses - Google Patents

Tripeptide antithrombotic ingredients, pharmaceutical preparations containing them and their uses

Info

Publication number
IL110933A
IL110933A IL11093394A IL11093394A IL110933A IL 110933 A IL110933 A IL 110933A IL 11093394 A IL11093394 A IL 11093394A IL 11093394 A IL11093394 A IL 11093394A IL 110933 A IL110933 A IL 110933A
Authority
IL
Israel
Prior art keywords
group
compound
acid
amino
arg
Prior art date
Application number
IL11093394A
Other languages
English (en)
Hebrew (he)
Other versions
IL110933A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL110933A0 publication Critical patent/IL110933A0/xx
Publication of IL110933A publication Critical patent/IL110933A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL11093394A 1993-09-14 1994-09-12 Tripeptide antithrombotic ingredients, pharmaceutical preparations containing them and their uses IL110933A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/121,134 US5430023A (en) 1990-09-28 1993-09-14 Tripeptide antithrombotic agents

Publications (2)

Publication Number Publication Date
IL110933A0 IL110933A0 (en) 1994-11-28
IL110933A true IL110933A (en) 1998-12-27

Family

ID=22394776

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11093394A IL110933A (en) 1993-09-14 1994-09-12 Tripeptide antithrombotic ingredients, pharmaceutical preparations containing them and their uses

Country Status (31)

Country Link
US (1) US5430023A (fr)
EP (1) EP0643073B1 (fr)
JP (1) JPH07149791A (fr)
KR (1) KR100312388B1 (fr)
CN (1) CN1055698C (fr)
AT (1) ATE160574T1 (fr)
AU (1) AU674773B2 (fr)
BR (1) BR9403542A (fr)
CA (1) CA2131982C (fr)
CO (1) CO4290364A1 (fr)
CY (1) CY2072B1 (fr)
CZ (1) CZ286139B6 (fr)
DE (1) DE69407006T2 (fr)
DK (1) DK0643073T3 (fr)
ES (1) ES2110186T3 (fr)
FI (1) FI944231A (fr)
GR (1) GR3026115T3 (fr)
HU (1) HU220620B1 (fr)
IL (1) IL110933A (fr)
MY (1) MY112879A (fr)
NO (1) NO310240B1 (fr)
NZ (1) NZ264438A (fr)
PE (1) PE43695A1 (fr)
PH (1) PH31655A (fr)
PL (1) PL176448B1 (fr)
RU (1) RU2105010C1 (fr)
SI (1) SI0643073T1 (fr)
TW (1) TW275622B (fr)
UA (1) UA32556C2 (fr)
YU (1) YU54194A (fr)
ZA (1) ZA947015B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2131367A1 (fr) * 1992-03-04 1993-09-16 Sandor Bajusz Nouveaux derives peptidiques anticoagulants et compositions pharmaceutiques en contenant; procede de fabrication
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
JPH09509943A (ja) * 1994-03-04 1997-10-07 イーライ・リリー・アンド・カンパニー 抗血栓剤
CA2143533A1 (fr) * 1994-03-04 1995-09-05 Kenneth D. Kurz Agents antithrombotiques
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5691356A (en) * 1994-03-21 1997-11-25 Bristol-Myers Squibb Company Disubstituted heterocyclic thrombin inhibitors
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
JP3539607B2 (ja) * 1997-02-19 2004-07-07 シャープ株式会社 空気調和機の運転制御システム
AU7292398A (en) 1997-05-15 1998-12-08 Eli Lilly And Company Antithrombotic compound
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
WO1999064395A1 (fr) * 1998-06-11 1999-12-16 Merck & Co., Inc. Composes d'amide heterocycliques utilises comme inhibiteurs d'adhesion cellulaire
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6172081B1 (en) 1999-06-24 2001-01-09 Novartis Ag Tetrahydroisoquinoline 3-carboxamide derivatives
EP1482882B1 (fr) * 2002-02-11 2011-09-14 Gold-T Tech, Inc. Dispositif implantable pour prevenir la formation de thrombus
US7205315B2 (en) 2003-09-27 2007-04-17 Sanofi-Aventis Deutschland Gmbh Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
CN102391360B (zh) * 2011-11-02 2013-07-03 东南大学 一种抗血栓和血小板聚集的小肽
KR102388531B1 (ko) * 2021-07-07 2022-04-21 이재호 특장차용 스마트 유압 시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
DE3827415A1 (de) * 1988-08-12 1990-02-15 Behringwerke Ag Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents

Also Published As

Publication number Publication date
HUT67849A (en) 1995-05-29
SI0643073T1 (en) 1998-08-31
ZA947015B (en) 1996-03-12
EP0643073B1 (fr) 1997-11-26
NO310240B1 (no) 2001-06-11
AU7294894A (en) 1995-03-30
CZ222094A3 (en) 1995-03-15
US5430023A (en) 1995-07-04
CZ286139B6 (cs) 2000-01-12
CN1055698C (zh) 2000-08-23
AU674773B2 (en) 1997-01-09
MY112879A (en) 2001-10-31
RU2105010C1 (ru) 1998-02-20
BR9403542A (pt) 1995-06-20
KR950008534A (ko) 1995-04-19
DE69407006T2 (de) 1998-04-16
DE69407006D1 (de) 1998-01-08
CA2131982A1 (fr) 1995-03-15
FI944231A0 (fi) 1994-09-13
JPH07149791A (ja) 1995-06-13
EP0643073A1 (fr) 1995-03-15
CY2072B1 (en) 1998-09-11
GR3026115T3 (en) 1998-05-29
ATE160574T1 (de) 1997-12-15
NZ264438A (en) 1996-06-25
KR100312388B1 (ko) 2001-12-28
HU9402626D0 (en) 1994-11-28
IL110933A0 (en) 1994-11-28
CN1106819A (zh) 1995-08-16
PL176448B1 (pl) 1999-05-31
PL305009A1 (en) 1995-03-20
DK0643073T3 (da) 1997-12-29
YU54194A (sh) 1997-01-08
UA32556C2 (uk) 2001-02-15
CO4290364A1 (es) 1996-04-17
HU220620B1 (hu) 2002-03-28
TW275622B (fr) 1996-05-11
PH31655A (en) 1999-01-12
CA2131982C (fr) 2003-07-29
NO943402L (no) 1995-03-15
ES2110186T3 (es) 1998-02-01
FI944231A (fi) 1995-03-15
RU94034734A (ru) 1996-07-20
PE43695A1 (es) 1995-12-09
NO943402D0 (no) 1994-09-13

Similar Documents

Publication Publication Date Title
EP0643073B1 (fr) Agents antithrombotiques à base de tripeptides
EP0542525B1 (fr) Composés antitrombotiques
EP0479489B1 (fr) Agents antithrombotiques à base de tripeptides
EP0670310B1 (fr) Conjugués des aldehydes de l'arginine et de bisulphite ainsi que leur utilisation comme inhibiteurs de thrombine et comme anticoagulants
RU2142469C1 (ru) Пептидные производные, их стереоизомеры или физиологически приемлемые соли, обладающие противотромбозной, противосвертывающей или противовоспалительной активностью, способ их получения, фармацевтическая композиция, способ подавления тромбина, способ подавления кининогеназ, применение соединений в качестве исходных в синтезе ингибитора тромбина
US5252566A (en) Antithrombotic agents
US5416093A (en) Antithrombotic agents
CZ129694A3 (en) Novel peptide derivatives
EP0672657B1 (fr) Composés pour l'inhibition de la thrombin

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees